Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AC013286.1 ENSG00000281042 10 76350749-76351228 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Group enriched 31 bone marrow: 1.3;epididymis: 4.7 adipose tissue: 0.0 AC018755.18 ENSG00000268500 19 51612091-51646889 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA009085 Approved Group enriched 5 appendix: 7.3;bone marrow: 14.2;lymph node: 3.6;spleen: 5.0 urinary bladder: 1.4 ACSL6 ACS2, FACL6, KIAA0837, LACS2, LACS5 ENSG00000164398 Acyl-CoA synthetase long-chain family member 6 5 131949973-132012243 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040470 Uncertain Group enriched 6 bone marrow: 18.0;cerebral cortex: 62.1;parathyroid gland: 22.1;seminal vesicle: 28.7;testis: 51.2 adrenal gland: 6.5 ADD2 ADDB ENSG00000075340 Adducin 2 (beta) 2 70607618-70768225 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009796, HPA034509, HPA034510 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 10 bone marrow: 40.3;cerebral cortex: 44.8 testis: 4.1 ADGRG3 GPR97, Pb99, PGR26 ENSG00000182885 Adhesion G protein-coupled receptor G3 16 57668187-57689378 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040469 Uncertain Group enriched 5 appendix: 19.4;bone marrow: 86.7 adipose tissue: 9.6 AICDA AID, ARP2, CDA2, HIGM2 ENSG00000111732 Activation-induced cytidine deaminase 12 8602166-8612871 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 11 appendix: 5.1;lymph node: 18.9;tonsil: 11.5 spleen: 1.0 ANKRD55 FLJ11795 ENSG00000164512 Ankyrin repeat domain 55 5 56099678-56233359 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051049 Approved Group enriched 5 lymph node: 4.2;testis: 17.2 tonsil: 1.9 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 BANK1 BANK, FLJ20706 ENSG00000153064 B-cell scaffold protein with ankyrin repeats 1 4 101411286-102074812 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037002 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 47.6;lymph node: 97.9;spleen: 78.5;thyroid gland: 21.5;tonsil: 90.9 urinary bladder: 13.3 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Approved Group enriched 10 appendix: 22.9;lymph node: 61.9;spleen: 41.3;tonsil: 54.0 urinary bladder: 4.5 BTLA BTLA1, CD272 ENSG00000186265 B and T lymphocyte associated 3 112463968-112499561 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047211, HPA062029 Supported Group enriched 7 appendix: 14.7;lymph node: 29.6;spleen: 14.8;tonsil: 25.7 urinary bladder: 3.1 CA1 Car1 ENSG00000133742 Carbonic anhydrase I 8 85327608-85379014 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006558, CAB025790 Supported Group enriched 31 bone marrow: 1219.6;colon: 1039.5;rectum: 2348.0 smooth muscle: 49.1 CAMP CAP18, FALL-39, FALL39, LL37 ENSG00000164047 Cathelicidin antimicrobial peptide 3 48223347-48225491 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB015949, CAB016522, HPA029874 Supported Group enriched 99 bone marrow: 1343.7;epididymis: 324.9 lymph node: 8.4 CASP5 ICE(rel)III ENSG00000137757 Caspase 5, apoptosis-related cysteine peptidase 11 104994235-105023168 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040937 Uncertain Group enriched 6 appendix: 20.7;colon: 16.2;duodenum: 10.4;rectum: 14.7;small intestine: 19.3 smooth muscle: 2.6 CCL19 CKb11, ELC, exodus-3, MIP-3b, SCYA19 ENSG00000172724 Chemokine (C-C motif) ligand 19 9 34689567-34691277 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067758 Supported Group enriched 5 adipose tissue: 171.7;appendix: 807.5;lymph node: 715.5;tonsil: 578.1 urinary bladder: 110.3 CCL3L3 MGC12815 ENSG00000276085 Chemokine (C-C motif) ligand 3-like 3 17 36194869-36196758 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 bone marrow: 7.4;gallbladder: 1.5 lymph node: 0.5 CCL7 FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7 ENSG00000108688 Chemokine (C-C motif) ligand 7 17 34270221-34272242 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 appendix: 3.6;bone marrow: 15.3 gallbladder: 1.1 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CCR9 CDw199, GPR-9-6, GPR28 ENSG00000173585 Chemokine (C-C motif) receptor 9 3 45886504-45903177 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006839 Uncertain Group enriched 6 appendix: 1.5;duodenum: 3.9;small intestine: 5.8;spleen: 1.2 lymph node: 0.5 CD177 HNA2A, NB1, PRV1 ENSG00000204936 CD177 molecule 19 43353659-43363172 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041820, HPA046601 Supported Group enriched 16 bone marrow: 193.4;colon: 159.0;prostate: 110.8;rectum: 184.1 appendix: 10.0 CD19 ENSG00000177455 CD19 molecule 16 28931939-28939346 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016110 Supported Group enriched 11 appendix: 38.8;lymph node: 85.0;spleen: 48.2;tonsil: 70.8 urinary bladder: 5.7 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB002505, HPA044658 Supported Approved Nucleus
Mitochondria Group enriched 8 appendix: 26.2;lymph node: 72.0;spleen: 65.9;tonsil: 44.3 urinary bladder: 6.2 CD79A IGA, MB-1 ENSG00000105369 CD79a molecule, immunoglobulin-associated alpha 19 41877120-41881372 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000019 Supported Group enriched 6 appendix: 275.4;lymph node: 522.9;spleen: 324.4;tonsil: 440.3 stomach: 62.7 CD79B B29, IGB ENSG00000007312 CD79b molecule, immunoglobulin-associated beta 17 63928740-63932354 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009178, CAB009751 Approved Uncertain Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 94.7;lymph node: 315.6;spleen: 160.3;tonsil: 196.1 bone marrow: 36.2 CEACAM4 CGM7 ENSG00000105352 Carcinoembryonic antigen-related cell adhesion molecule 4 19 41618971-41627074 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 appendix: 6.8;bone marrow: 14.0;spleen: 9.1 adipose tissue: 1.7 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supported Group enriched 6 bone marrow: 110.9;colon: 184.1;esophagus: 174.2;gallbladder: 190.2;lung: 406.1;rectum: 236.9 appendix: 38.9 CETP BPIFF ENSG00000087237 Cholesteryl ester transfer protein, plasma 16 56961850-56983845 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adipose tissue: 36.8;liver: 21.6;lymph node: 47.1;placenta: 50.0;spleen: 79.2 thyroid gland: 8.4 CHIT1 CHI3, CHIT ENSG00000133063 Chitinase 1 (chitotriosidase) 1 203212827-203273641 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010575 Approved Group enriched 9 bone marrow: 31.3;breast: 10.7;cervix, uterine: 13.4;lung: 53.2;lymph node: 21.5 prostate: 2.9 CHRDL2 BNF1 ENSG00000054938 Chordin-like 2 11 74696429-74731385 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021771 Uncertain Uncertain Mitochondria Group enriched 9 appendix: 162.3;endometrium: 128.0;gallbladder: 169.0;smooth muscle: 181.2;urinary bladder: 45.0 cervix: 14.5 CLEC17A FLJ45910 ENSG00000187912 C-type lectin domain family 17, member A 19 14583084-14611157 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 appendix: 17.3;lymph node: 30.8;spleen: 19.8;tonsil: 29.7 urinary bladder: 2.4 CLEC4D CD368, CLECSF8, Mpcl ENSG00000166527 C-type lectin domain family 4, member D 12 8509475-8522366 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004906 Approved Group enriched 6 appendix: 10.7;bone marrow: 42.9 cervix: 4.8 CLEC4G LSECtin, UNQ431 ENSG00000182566 C-type lectin domain family 4, member G 19 7728957-7733906 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003789, HPA014044 Supported Group enriched 6 adipose tissue: 18.5;liver: 27.6;lymph node: 17.0 urinary bladder: 3.5 CLEC4M CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN ENSG00000104938 C-type lectin domain family 4, member M 19 7763149-7769605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033689, CAB033691, HPA042661 Supported Group enriched 7 liver: 34.7;lymph node: 20.6;placenta: 12.4 testis: 3.3 CNR2 CB2 ENSG00000188822 Cannabinoid receptor 2 (macrophage) 1 23870526-23913362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009719 Uncertain Group enriched 7 appendix: 3.2;lymph node: 8.8;spleen: 8.1;tonsil: 7.2 bone marrow: 1.0 CPLX3 CPX-III ENSG00000213578 Complexin 3 15 74826547-74831802 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 prostate: 127.7;spleen: 75.8 cerebral cortex: 12.9 CR2 CD21 ENSG00000117322 Complement component (3d/Epstein Barr virus) receptor 2 1 207454230-207489895 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002659, HPA052942, HPA060715 Supported Group enriched 22 appendix: 70.8;lymph node: 207.6;spleen: 101.3;tonsil: 159.4 kidney: 6.1 CROCC2 ENSG00000226321 Ciliary rootlet coiled-coil, rootletin family member 2 2 240906330-240993311 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA048678 Uncertain Group enriched 5 fallopian tube: 8.6;spleen: 3.3 lung: 1.1 CXCL13 ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13 ENSG00000156234 Chemokine (C-X-C motif) ligand 13 4 77511753-77611834 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052613 Uncertain Group enriched 7 appendix: 170.3;lymph node: 606.7;spleen: 430.3;tonsil: 411.9 urinary bladder: 60.1 DNMT3L MGC1090 ENSG00000142182 DNA (cytosine-5-)-methyltransferase 3-like 21 44246339-44262216 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA055234, HPA066780 Uncertain Approved Nuclear speckles Group enriched 6 kidney: 7.4;liver: 10.8;lymph node: 2.3 spleen: 1.1 DPPA4 FLJ10713 ENSG00000121570 Developmental pluripotency associated 4 3 109326141-109337572 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020678, HPA035249, HPA035250 Supported Group enriched 8 bone marrow: 2.8;placenta: 3.0;testis: 7.7 tonsil: 0.5 EN1 ENSG00000163064 Engrailed homeobox 1 2 118842171-118847678 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level No evidence CAB014884, HPA073141 Approved Supported Nucleus
Nucleoli Group enriched 13 adipose tissue: 1.3;breast: 1.0;lymph node: 1.9;skeletal muscle: 4.7;skin: 2.2 testis: 0.1 FAM129C BCNP1, FLJ39802 ENSG00000167483 Family with sequence similarity 129, member C 19 17523301-17553839 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043277 Approved Group enriched 15 appendix: 14.5;bone marrow: 11.3;lymph node: 28.5;spleen: 37.6;tonsil: 9.7 gallbladder: 1.3 FAM178B LOC51252 ENSG00000168754 Family with sequence similarity 178, member B 2 96875882-96986592 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042516, HPA062110 Uncertain Uncertain Nuclear speckles
Golgi apparatus Group enriched 5 bone marrow: 11.4;epididymis: 6.6;spleen: 17.0;testis: 7.4 fallopian tube: 2.0 FAM221B C9orf128 ENSG00000204930 Family with sequence similarity 221, member B 9 35816391-35828747 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023011, HPA026577 Uncertain Group enriched 6 bone marrow: 2.4;testis: 10.4 prostate: 1.1 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Approved Group enriched 7 appendix: 22.9;lymph node: 48.1;spleen: 53.7;tonsil: 39.4 adipose tissue: 5.7 FCN1 FCNM ENSG00000085265 Ficolin (collagen/fibrinogen domain containing) 1 9 134905890-134917963 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000685, HPA001295, CAB016760 Supported Group enriched 5 appendix: 331.6;bone marrow: 635.8 spleen: 96.4 FCRL2 CD307b, FCRH2, IRTA4, SPAP1 ENSG00000132704 Fc receptor-like 2 1 157745733-157777132 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 appendix: 16.9;lymph node: 28.7;spleen: 26.3;tonsil: 24.6 rectum: 3.1 FCRL3 CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e ENSG00000160856 Fc receptor-like 3 1 157674321-157700857 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015508 Approved Group enriched 12 appendix: 18.8;lymph node: 56.6;spleen: 37.3;tonsil: 33.6 urinary bladder: 2.9 FCRL4 CD307d, FCRH4, IGFP2, IRTA1 ENSG00000163518 Fc receptor-like 4 1 157573749-157598080 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054030 Approved Group enriched 5 appendix: 3.7;lymph node: 4.5;tonsil: 10.1 spleen: 1.2 FCRLA FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595 ENSG00000132185 Fc receptor-like A 1 161706972-161714352 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016545 Supported Group enriched 10 appendix: 32.5;lymph node: 81.6;spleen: 57.4;tonsil: 90.1 urinary bladder: 6.5 G0S2 ENSG00000123689 G0/G1 switch 2 1 209675420-209676388 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 adipose tissue: 956.4;bone marrow: 939.4;skeletal muscle: 240.6 appendix: 140.8 GJB6 CX30, DFNA3, ED2, EDH, HED ENSG00000121742 Gap junction protein, beta 6, 30kDa 13 20221971-20232395 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014846 Supported Cell Junctions Group enriched 5 bone marrow: 47.6;cerebral cortex: 39.6;esophagus: 150.3;skin: 32.0 tonsil: 12.7 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 HBA2 HBA-T2 ENSG00000188536 Hemoglobin, alpha 2 16 172847-173710 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB038417, HPA043780 Supported Group enriched 26 bone marrow: 18412.0;placenta: 4269.5 spleen: 435.5 HBQ1 HBQ ENSG00000086506 Hemoglobin, theta 1 16 180453-181181 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062473 Supported Approved Lipid droplets Group enriched 8 bone marrow: 14.7;cerebral cortex: 3.0 placenta: 1.1 HBZ HBZ-T1, HBZ1 ENSG00000130656 Hemoglobin, zeta 16 152687-154503 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 12 bone marrow: 2.4;placenta: 1.0;testis: 3.9 skin: 0.2 HEMGN CT155, EDAG, NDR ENSG00000136929 Hemogen 9 97926791-97944856 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019572, HPA019604, HPA019606 Supported Group enriched 14 bone marrow: 142.0;testis: 87.7 placenta: 8.1 HIST1H2BB H2B/f, H2BFF ENSG00000276410 Histone cluster 1, H2bb 6 26043227-26123904 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042205, HPA043013, HPA048671 Supported Approved Nucleoplasm
Cytosol Group enriched 6 bone marrow: 1.0;testis: 3.2 lymph node: 0.3 HIST1H3A H3/A, H3FA ENSG00000275714 Histone cluster 1, H3a 6 26020490-26020900 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042570 Supported Group enriched 5 bone marrow: 6.7;epididymis: 1.8;testis: 3.7 cervix: 0.8 HLA-DOB ENSG00000241106 Major histocompatibility complex, class II, DO beta 6 32812763-32817048 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013846 Approved Group enriched 5 lymph node: 19.9;spleen: 18.8;tonsil: 31.8;urinary bladder: 8.6 colon: 3.6 HTR3A 5-HT3A, 5-HT3R, HTR3 ENSG00000166736 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11 113974881-113990313 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 5 appendix: 2.9;lymph node: 7.9;tonsil: 7.4 small intestine: 1.1 IFIT1B bA149I23.6, IFIT1L ENSG00000204010 Interferon-induced protein with tetratricopeptide repeats 1B 10 89378056-89385205 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA062924 Approved Group enriched 97 bone marrow: 15.3;placenta: 4.1 epididymis: 0.0 IGLL1 14.1, CD179B, IGL5, IGLL, IGVPB ENSG00000128322 Immunoglobulin lambda-like polypeptide 1 22 23573125-23580308 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051134, HPA071406 Approved Approved Endoplasmic reticulum Group enriched 17 bone marrow: 44.3;testis: 16.1 tonsil: 1.7 IL24 C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16 ENSG00000162892 Interleukin 24 1 206897443-206904139 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025972 Uncertain Group enriched 5 appendix: 17.9;lymph node: 37.6;spleen: 30.0;tonsil: 28.5 urinary bladder: 5.6 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KLRC2 CD159c, NKG2-C ENSG00000205809 Killer cell lectin-like receptor subfamily C, member 2 12 10426854-10442300 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA058052 Approved Plasma membrane Group enriched 6 cerebral cortex: 17.4;spleen: 8.3 stomach: 2.0 KRT73 K6IRS3, KRT6IRS3 ENSG00000186049 Keratin 73, type II 12 52607570-52618559 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044031 Supported Group enriched 7 lymph node: 2.6;skin: 12.2 appendix: 1.0 LILRB3 CD85a, HL9, ILT5, LIR-3, LIR3 ENSG00000204577 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 19 54216278-54223506 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 adipose tissue: 5.3;appendix: 10.4;bone marrow: 8.3;lung: 8.7;spleen: 9.4;urinary bladder: 6.9 placenta: 1.3 LIMD2 MGC10986 ENSG00000136490 LIM domain containing 2 17 63695902-63701172 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062867 Approved Vesicles Group enriched 5 appendix: 145.1;bone marrow: 71.3;lymph node: 259.7;spleen: 195.3;tonsil: 145.7 urinary bladder: 31.4 LRTM1 HT017 ENSG00000144771 Leucine-rich repeats and transmembrane domains 1 3 54918237-54967088 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013839 Uncertain Group enriched 5 esophagus: 4.3;skeletal muscle: 9.1;spleen: 9.0 prostate: 1.4 LTB p33, TNFC, TNFSF3 ENSG00000227507 Lymphotoxin beta (TNF superfamily, member 3) 6 31580525-31582522 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048884 Approved Approved Centrosome Group enriched 8 appendix: 19.4;lymph node: 22.5;spleen: 26.4;tonsil: 10.6 bone marrow: 2.6 MCEMP1 C19orf59, MGC132456 ENSG00000183019 Mast cell-expressed membrane protein 1 19 7676628-7679826 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014731 Supported Group enriched 9 appendix: 28.5;bone marrow: 43.9;lung: 110.4 smooth muscle: 6.9 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MEF2B RSRFR2 ENSG00000213999 Myocyte enhancer factor 2B 19 19145568-19170289 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004734 Supported Group enriched 9 appendix: 18.2;lymph node: 46.3;tonsil: 28.2 spleen: 3.3 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 NEU4 ENSG00000204099 Sialidase 4 2 241808825-241817413 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037394, HPA037395 Uncertain Group enriched 7 bone marrow: 2.4;cerebral cortex: 6.4;colon: 8.5;duodenum: 5.7;liver: 4.1;rectum: 3.9;small intestine: 5.4 gallbladder: 0.8 NKX2-5 CSX, CSX1, NKX2.5, NKX2E, NKX4-1 ENSG00000183072 NK2 homeobox 5 5 173232109-173235357 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065034 Approved Nucleoplasm
Cytosol Group enriched 130 heart muscle: 33.8;spleen: 14.8 breast: 0.1 NME8 CILD6, NM23-H8, SPTRX2, TXNDC3 ENSG00000086288 NME/NM23 family member 8 7 37848597-37900401 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB016416, HPA019259 Supported Group enriched 14 bone marrow: 8.2;testis: 18.3 spleen: 0.9 NOS2 HEP-NOS, iNOS, NOS, NOS2A ENSG00000007171 Nitric oxide synthase 2, inducible 17 27756766-27800499 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002014 Approved Group enriched 5 appendix: 19.6;colon: 7.2;duodenum: 12.6;rectum: 10.0;small intestine: 24.6;urinary bladder: 6.7 smooth muscle: 2.5 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 NR5A1 AD4BP, ELP, FTZ1, FTZF1, SF-1 ENSG00000136931 Nuclear receptor subfamily 5, group A, member 1 9 124481236-124507430 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adrenal gland: 138.2;ovary: 36.3;spleen: 154.3 testis: 19.6 NTNG2 KIAA1857, Lmnt2, NTNG1 ENSG00000196358 Netrin G2 9 132161676-132244534 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071290 Approved Group enriched 5 bone marrow: 26.5;cerebral cortex: 18.5;parathyroid gland: 16.0;prostate: 8.6 spleen: 3.2 OLR1 CLEC8A, LOX-1, SCARE1 ENSG00000173391 Oxidized low density lipoprotein (lectin-like) receptor 1 12 10158301-10172138 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050798 Supported Nucleoplasm
Vesicles
Plasma membrane Group enriched 6 appendix: 42.1;cerebral cortex: 32.8;lung: 146.2;placenta: 159.6 bone marrow: 15.8 OTOA CT108, DFNB22 ENSG00000155719 Otoancorin 16 21678514-21760729 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041405 Uncertain Group enriched 14 spleen: 2.7;testis: 6.2 epididymis: 0.3 P2RX5 LRH-1, P2X5 ENSG00000083454 Purinergic receptor P2X, ligand gated ion channel, 5 17 3672199-3696404 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA021948, HPA067827 Supported Supported Cytosol Group enriched 10 appendix: 42.6;lymph node: 90.9;spleen: 75.5;tonsil: 48.4 bone marrow: 6.2 PF4 CXCL4, SCYB4 ENSG00000163737 Platelet factor 4 4 73981077-73982124 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026008, HPA052485 Supported Group enriched 5 bone marrow: 53.9;spleen: 13.7 placenta: 6.4 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002513, HPA040368, HPA062096, HPA064404 Supported Supported Nucleoplasm Group enriched 6 appendix: 37.8;lymph node: 62.5;spleen: 37.2;tonsil: 45.5 urinary bladder: 8.1 PRRT4 ENSG00000224940 Proline-rich transmembrane protein 4 7 128350325-128361685 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA046373, HPA052681 Uncertain Approved Nucleoplasm
Peroxisomes
Plasma membrane Group enriched 12 adipose tissue: 15.7;bone marrow: 41.2 cerebral cortex: 2.3 RGS13 ENSG00000127074 Regulator of G-protein signaling 13 1 192636138-192660306 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA044952 Uncertain Group enriched 6 appendix: 14.8;lymph node: 69.2;tonsil: 38.3 small intestine: 7.3 RP11-277P12.6 ENSG00000255641 12 10412312-10436001 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA062570 Uncertain Group enriched 7 cerebral cortex: 8.2;spleen: 6.2 bone marrow: 1.0 S100A8 60B8AG, CAGA, CFAG, CGLA, MRP8, P8 ENSG00000143546 S100 calcium binding protein A8 1 153390032-153391188 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002791, HPA024372 Supported Supported Intermediate filaments Group enriched 9 bone marrow: 14952.4;esophagus: 12812.0;tonsil: 5078.4 appendix: 1261.4 S100A9 60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14 ENSG00000163220 S100 calcium binding protein A9 1 153357854-153361027 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004193, CAB009441 Supported Supported Nucleoplasm
Cell Junctions
Cytosol Group enriched 6 bone marrow: 21012.0;esophagus: 24343.4 tonsil: 4079.1 SEC14L4 dJ130H16.5, TAP3 ENSG00000133488 SEC14-like lipid binding 4 22 30488913-30505711 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069748 Approved Centrosome Group enriched 8 bone marrow: 5.0;liver: 10.3;lung: 6.9;parathyroid gland: 10.3;testis: 7.1 adrenal gland: 0.9 SEMA3D coll-2, Sema-Z2 ENSG00000153993 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D 7 84995553-85186855 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA037522 Uncertain Approved Golgi apparatus
Plasma membrane Group enriched 5 spleen: 67.1;thyroid gland: 76.0 prostate: 13.5 SEPT4 ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2 ENSG00000108387 Septin 4 17 58520250-58540818 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006855, HPA021587, HPA022905 Supported Supported Nucleoplasm Group enriched 5 adrenal gland: 218.2;cerebral cortex: 288.7;spleen: 57.8 adipose tissue: 36.8 SERPINA9 CENTERIN, GCET1, SERPINA11b ENSG00000170054 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 14 94462717-94479689 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 10 appendix: 17.7;lymph node: 51.0;tonsil: 68.9 epididymis: 4.5 SIGLEC11 ENSG00000161640 Sialic acid binding Ig-like lectin 11 19 49948985-49961172 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060278 Approved Group enriched 7 ovary: 79.9;spleen: 32.2 adrenal gland: 8.2 SIT1 SIT ENSG00000137078 Signaling threshold regulating transmembrane adaptor 1 9 35649295-35650950 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018506 Supported Group enriched 5 appendix: 25.6;lymph node: 56.9;spleen: 22.3;tonsil: 30.9 urinary bladder: 6.3 SLC22A16 CT2, FLIPT2, OAT6, OKB1 ENSG00000004809 Solute carrier family 22 (organic cation/carnitine transporter), member 16 6 110424687-110476641 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036902 Uncertain Group enriched 8 bone marrow: 13.0;parathyroid gland: 16.1;testis: 38.4 smooth muscle: 2.7 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 SP140 LYSP100-A, LYSP100-B ENSG00000079263 SP140 nuclear body protein 2 230203110-230313215 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006162, HPA067493 Supported Approved Nucleoli fibrillar center
Mitochondria Group enriched 6 appendix: 34.0;lymph node: 65.2;spleen: 38.9;tonsil: 52.9 urinary bladder: 7.9 SPATC1 MGC61633, SPATA15, SPERIOLIN ENSG00000186583 Spermatogenesis and centriole associated 1 8 144012414-144047085 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039590, HPA040220 Uncertain Group enriched 5 bone marrow: 6.2;testis: 21.8 appendix: 2.6 SRGN PPG, PRG, PRG1 ENSG00000122862 Serglycin 10 69088106-69104811 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000759 Supported Group enriched 6 appendix: 1146.8;bone marrow: 5150.0 gallbladder: 510.5 STAP1 BRDG1, STAP-1 ENSG00000035720 Signal transducing adaptor family member 1 4 67558728-67607337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038529 Supported Uncertain Nucleoplasm
Vesicles Group enriched 6 appendix: 24.7;kidney: 13.1;lymph node: 60.3;spleen: 27.0;tonsil: 58.9 testis: 6.1 TIMD4 ENSG00000145850 T-cell immunoglobulin and mucin domain containing 4 5 156919282-156963255 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015625, CAB026027 Approved Approved Plasma membrane
Cytosol Group enriched 6 lymph node: 64.4;testis: 161.6 adipose tissue: 17.7 TLR10 CD290 ENSG00000174123 Toll-like receptor 10 4 38772239-38782990 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 appendix: 22.0;lymph node: 52.3;spleen: 35.2;tonsil: 46.8 urinary bladder: 5.7 TMEM156 FLJ23235 ENSG00000121895 Transmembrane protein 156 4 38966744-39032922 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 appendix: 12.2;lymph node: 28.1;spleen: 15.4;tonsil: 25.3;urinary bladder: 5.9 gallbladder: 3.1 TNFRSF13C BAFFR, CD268 ENSG00000159958 Tumor necrosis factor receptor superfamily, member 13C 22 41922023-41926818 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003246, CAB008380 Supported Uncertain Nucleus Group enriched 10 appendix: 23.8;lymph node: 46.7;spleen: 44.4;tonsil: 51.9 bone marrow: 4.0 TRIM58 BIA2 ENSG00000162722 Tripartite motif containing 58 1 247857199-247878205 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023637 Uncertain Group enriched 6 bone marrow: 16.2;placenta: 6.8;testis: 6.6;thyroid gland: 21.9 prostate: 2.0 TUBB1 dJ543J19.4 ENSG00000101162 Tubulin, beta 1 class VI 20 59019254-59026654 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004286, HPA043640, HPA046280 Approved Supported Microtubules Group enriched 5 bone marrow: 4.8;lung: 1.9;placenta: 1.2;spleen: 5.3;testis: 1.5 gallbladder: 0.5 VIP ENSG00000146469 Vasoactive intestinal peptide 6 152750798-152759765 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017324, CAB018649, HPA072701 Supported Approved Endoplasmic reticulum Group enriched 5 appendix: 215.7;colon: 72.6;rectum: 69.1;small intestine: 53.7;smooth muscle: 57.4 duodenum: 17.3